State of Wisconsin Investment Board
LENZ

State of Wisconsin Investment Board’s LENZ Therapeutics LENZ Stock Holding History

State of Wisconsin Investment Board’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$148K Sell
16,220
-16,015
-50% -$225K ﹤0.01% 2384
2025
Q4 		$516K Buy
32,235
+8,122
+34% +$237K ﹤0.01% 1944
2025
Q3 		$1.12M Buy
+24,113
New +$887K ﹤0.01% 1571

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

State of Wisconsin Investment Board's LENZ Position: Q1 2026 in Review

State of Wisconsin Investment Board reduced its LENZ Therapeutics (LENZ) stake by 50% in Q1 2026, selling an estimated $225K and leaving 16,220 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #2384.

State of Wisconsin Investment Board first reported a position in LENZ in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.12M in Q3 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q1 2026.

  • State of Wisconsin Investment Board held 16,220 shares of LENZ Therapeutics worth $148K as of Q1 2026.
  • State of Wisconsin Investment Board sold 16,015 LENZ Therapeutics shares in Q1 2026, an estimated $225K.
  • LENZ Therapeutics made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #2384 holding.
  • State of Wisconsin Investment Board first reported a position in LENZ Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • State of Wisconsin Investment Board's LENZ Therapeutics position peaked at $1.12M in Q3 2025.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.